Skip to content
Medibio Logo Medibio Logo Medibio Logo
  • Science
  • Clinical
  • Investors
    • STOCK INFORMATION
    • ASX ANNOUNCEMENTS
    • CORPORATE GOVERNANCE
    • FAQs
    • CONTACT US
  • About
    • OUR MISSION
    • MANAGEMENT
    • BOARD OF DIRECTORS
    • GROWTH & ADVOCACY ADVISORY BOARD
    • COMPANY NEWS
    • PRIVACY AND TERMS
  • Contact
Previous Next

Medibio (ASX:MEB) talks depression diagnostic technology

Medibio Development2017-06-06T13:43:08-05:00March 27th, 2017|

Recent Posts

  • Medibio Limited (ASX:MEB; OTC:MDBIF) Corporate Intro Webinar
  • 5 ASX listed healthcare stocks to look at in October 2021
  • Biotech Daily – Medibio launched LUCA for stress
  • The Courier Mail – Biometric data gives insights into staff wellbeing
  • Pitt Street Research 

Archives

  • March 2022
  • October 2021
  • August 2021
  • November 2020
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • December 2017
  • July 2017
  • June 2017
  • March 2017
  • December 2016
  • September 2016
  • June 2016

Categories

  • Corporate Health
  • employee wellbeing
  • employee wellness
  • ilumen
  • Mental Health
  • Uncategorised
  • Contact
  • Investors
  • Company News
  • Press & Media
  • Articles and Blogs
  • Careers

Follow Us:

Contact Us

United States HQ:
8696 Eagle Creek Circle Savage, MN 55378


Australia
Melbourne:
Level 4, 100 Albert Road South Melbourne VIC 3205

Perth:
PO BOX 422 Mount Lawley WA 6929

Medibio Limited © 2022. All Rights Reserved.

Page load link
Go to Top